This article was originally published in The Gray Sheet
House-Senate conference committee approves bill to fund FDA through fiscal 2010, including $2.36 billion in appropriations, on Sept. 30. The total is $306 million more than 2009 funding and $7 million more than the president requested. The bill also approves the collection of $893 million in industry user fees. Medical device activities will get $349.3 million in appropriations under the bill, plus $57 million in user fees. The conference agreement still needs approval by the full House and Senate, and the president's signature. The government will be funded at fiscal 2009 levels though Oct. 31 under a continuing resolution
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.